Episodios
-
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO of THREAD research to discuss the importance of patient listening and in-study interviews to build better clinical trial endpoints. They delve into the differences between enterprise and point solutions, challenges with standardization, and the influence of evolving technologies in the eCOA industry.
-
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring patient experience data throughout the clinical journey. They delve into the significance of patient-centered clinical outcome assessments for endpoint selection in clinical trials, prioritizing diversity and inclusion across global clinical sites with the help of translation services providers, and shifting trends towards DCTs.
-
¿Faltan episodios?
-
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the need for technological innovation in clinical research. The conversation highlights key challenges faced in transitioning from academia to entrepreneurship, and the importance of storytelling in securing funding. Key facets of success in this realm place emphasis on assembling diverse teams with expertise in platform technologies, enterprise architecture, and how collaboration between technologists and clinical research experts helps build scalable clinical research solutions.
-
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a multimillion dollar eClinical company. Continuing the conversation in part two, the pair explore the commercial aspects of e-clinical solutions, particularly focusing on the landscape of Decentralized Clinical Trials (DCT). The conversation centers around evolution of DCT during the pandemic, the merging of DCT with Electronic Clinical Outcome Assessments (ECOA), and the need for a hybrid approach - balancing remote and on-site research modalities. There is an emphasis on the importance of prioritizing core measurements over excessive data collection, leveraging technology for speed, scale, and access, and envisioning a future where digital transformation enhances clinical research outcomes.
-
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ethical considerations surrounding patient/caregiver consent, to the intricate timing challenges of data collection, the conversation examines how involvement in a study impacts on disease states and patient wellbeing, with further insight into how burden is extended to families and caregivers.
-
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials
-
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for flexibility in technology uptake at research sites. With additional considerations to be made, such as ensuring regulatory compliance, and enforcing standardized metrics in assessing DCT performance, this episode provides valuable insight into the dynamic and relatively novel landscape of decentralization in clinical trials.
-
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how AI can generate study protocols, consent forms, and more, saving time and resources. Join us to unravel the potential of AI in reshaping the future of medical research and clinical trial operations.
-
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Florence Mowlem, VP of Science at ObvioHealth, to discuss maximizing patient accessibility in trial design. This includes implementing accommodations for patients with physical and cognitive limitations, and ensuring thoughtful applications of electronic modalities.
-
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Dr. Elizabeth Bacci, Senior Research Scientist at Evidera., to discuss critical aspects of developing meaningful and relevant Digital Health instruments. The conversation emphasizes the importance of aligning digital health tools with individual patient needs, and prioritizing the patient's perspective when developing instruments that are fit for purpose in today’s patient outcomes, conducting qualitative interviews and defining meaningful relevant endpoints.
-
Mark Wade interviews Paul O'Donohoe, Senior Director of Product for eCOA and COA at Medidata. They delve into the challenges and opportunities of adopting decentralized clinical trials (DCTs) and explore topics such as mixed modalities for data capture, patient burden, site-centricity, HTML5-based app wrappers, regulatory advancements during the pandemic, and the importance of flexibility in clinical trial technology adoption.
-
Tune in to our chat with Aaron McCormick, Associate Director, eCOA Implementation at Moderna, to unravel the importance of standardized eCOA systems across trials and indications. Explore compliance reporting, document management, and TMF guidelines, and gain invaluable insights for successful trial execution and inspection readiness.
-
What is implementation science, and how can it revolutionize patient-centered healthcare? Join Dr. Meredith Smith in conversation with Mark Wade as they discuss this systematic approach to bridging the gap between healthcare innovations and routine settings. Explore its potential to improve patient outcomes and reduce therapy wastage, while gaining attention from regulatory authorities.
-
In this episode, host Mark Wade is joined by Bill Byrom, the VP of Product Intelligence and Positioning at Signant Health, as they explore the world of capturing data from oncology patients and discuss the challenges of traditional data collection methods using quality-of-life instruments during clinic visits.
-
In our first episode of LifeSci Talks, Global Practice Leader & COA SME of TransPerfect Life Sciences sits down with Dr. Elin Haf Davies, CEO of Aparito, to discuss the need for child-friendly study designs and endpoints in pediatric clinical trials, highlighting the potential impact on future generations.
